Adam Johnson

• The placement agent in iBio’s $6.2 million warrant inducement transaction
• Venrock in Surrozen’s $192 million PIPE financing
• The placement agents in Aligos Therapeutics, Inc.’s $105 million PIPE financing
• The underwriters in Metsera’s $275 million initial public offering
• Disc Medicine in its $259 million follow-on offering, $178 million follow-on offering, and $200 million at-the-market offering
• TransCode Therapeutics in its $10 million registered direct offering, $8 million private placement, and $3 million registered direct offering
• The placement agents in Olema Pharmaceuticals’ $250 million PIPE financing
• Septerna, Inc. in its $288 million initial public offering
• ProQR Therapeutics in its $63 million follow-on offering and concurrent $12 million private placement
• RA Capital Management in Eliem Therapeutics’ $120 million PIPE financing
• AVROBIO in its reverse merger with Tectonic Therapeutics and concurrent private placement
• Monte Rosa Therapeutics, Inc. in its $100 million follow-on offering
• Vivani Medical in its $75 million at-the-market offering and $15 million registered direct offering, and $8.25 million private placement
• The placement agent and sales agent in Acrivon Therapeutic’s $130 million PIPE financing and $25 million at-the-market offering
• Akero Therapeutics in its $367 million follow-on offering
• The placement agents in Outlook Therapeutics, Inc.’s $60 million PIPE financing
• ProMIS Neurosciences in its $122.7 million PIPE financing and $25 million at-the-market offering
• Rapid Micro Biosystems in its $10 million at-the-market offering
• Medicxi Ventures in its purchase of $30 million of common stock in Phatham Pharmaceuticals in a secondary sale from Takeda Pharmaceutical Company Limited
• The underwriters in PACS Group’s $517 million initial public offering and $690 million primary and secondary follow on offering
• The underwriters and sales agent in CureVac’s $213 million initial public offering, $450 million follow on offering, and $250 million follow-on offering, and $600 million at-the-market offering*
• Evelo Biosciences in its $85 million initial public offering, $50 million at-the-market offering, $45 million follow-on offering, $68 million follow-on offering, $7.5 million private placement, $79 million follow-on offering, and $75 million at-the-market offering*
• The underwriters in Verrica Pharmaceutical’s $32 million registered direct offering*
• Syneos in its $600 million notes offering*
• The underwriters in NewLink Genetics’ $51 million follow-on offering*
• Atea Pharmaceuticals in its $300 million initial public offering*
• The underwriters in Sigilon Therapeutics’ $126 million initial public offering*
• The underwriters in Fusion Pharmaceuticals’ $212.5 million initial public offering*
• Akebia Therapeutics in its merger with Keryx Biopharmaceuticals*
• The underwriters in Cara Therapeutics $86 million follow-on offering and $127 million follow-on offering*

*Denotes experience prior to joining Goodwin.

• The underwriters in J. Jill’s $71 million primary and secondary follow-on offering
• MeridianLink, Inc. in its $44 million public offering
• The dealer manager in WeWork’s exchange offer of $669 million senior notes*
• Evertec in its $200 million secondary follow-on offering*
• Silver Lake Partners in its $12.5 billion acquisition and take-private of Qualtrics*
• Oddity Tech in its $424 million initial public offering*
• The underwriters in CuriosityStream’s $88 million follow-on offering*
• The underwriters in Skyward Specialty Insurance’s $134 million initial public offering, $153 million follow-on offering, and $89 million secondary follow-on offering*
• The underwriters in Strategic Education’s $192 million follow-on offering*
• The underwriters in CarParts.com’s $64 million follow-on offering*
• The initial purchasers in Kaiser Aluminum’s $500 million notes offering*
• The initial purchasers in Icahn Enterprises’ $750 million notes offering, $500 million notes offering, $300 million notes offering, $300 million notes offering, and $500 million notes offering*
• The initial purchasers in Citadel’s notes offering*
• UGI International in its $350 million notes offering*
• LogMeIn in its merger with Citrix’s GetGo subsidiary*
• Spectrum Equity in its investment in Origami Risk*
• Harvest Partners in its investment in GPM Investments*
• Landon Capital in its investment in NSA Industries*
• The underwriters in a mixed primary and secondary offering of $71.3 million of J. Jill common stock
• The underwriters in PACS Group $450 million initial public offering and $690 million follow-on offering
• MeridianLink, Inc. in its $44 million public offering
• Shift4 Payments in its $345 million initial public offering, $485 million follow-on offering and $495 million secondary transaction offering*
• Mister Car Wash in its $562.5 million initial public offering*
• Endeavor Group Holdings in its $511.3 million initial public offering and concurrent acquisition of the UFC*
• The UFC in its $21.4 billion merger with WWE and creation of TKO Holdings*
• Solo Stove in its $59.35 million follow-on offering*

*Denotes experience prior to joining Goodwin.